Keyphrases
New Drug Targets
100%
Glioblastoma
100%
Tunneling Nanotubes
100%
Tumor Heterogeneity
57%
Tumor Microtubes
57%
Novel Therapeutics
14%
Malignancy
14%
Tumor
14%
Expanded Access
14%
Therapeutic Targeting
14%
Molecular Diversity
14%
Actin
14%
Tumor Microenvironment
14%
Next-generation Sequencing Technology
14%
Malignant Tumor
14%
Difficult-to-treat
14%
Cellular Heterogeneity
14%
Tumor Mass
14%
Postgenomics
14%
Nontumor
14%
Pharmacological Targeting
14%
Medicine and Dentistry
Glioblastoma
100%
Nanotube
100%
Tumor
100%
Tumour Heterogeneity
28%
Malignant Neoplasm
14%
Cancer
14%
Tumor Microenvironment
14%
Next Generation Sequencing
14%
Actin
14%
Biochemistry, Genetics and Molecular Biology
Next Generation Sequencing
100%
Actin
100%
Genomics
100%
Pharmacology, Toxicology and Pharmaceutical Science
Nanotube
100%
Glioblastoma
100%
Malignant Neoplasm
14%
Actin
14%
Tumor Microenvironment
14%
Veterinary Science and Veterinary Medicine